CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritis. (Q45925746)
Jump to navigation
Jump to search
scientific article published in September 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritis. |
scientific article published in September 2013 |
Statements
1 reference
CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritis. (English)
1 reference
Maxime Dougados
1 reference
Bernard Combe
1 reference
Xavier Mariette
1 reference
Jérémie Sellam
1 reference
Stéphanie Rouanet
1 reference
Houria Hendel-Chavez
1 reference
Corinne Miceli-Richard
1 reference
Jean Sibilia
1 reference
Jacques Tebib
1 reference
Rosemary Jourdan
1 reference
Yassine Taoufik
1 reference
1 September 2013
1 reference
65
1 reference
9
1 reference
2253-2261
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference